Navigation Links
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
Date:5/9/2008

(33,333) (23,254)

OTHER INCOME:

Interest and other (expense) income, net (1,203) 1,441

NET LOSS $(34,536) $(21,813)

NET LOSS PER COMMON SHARE

Basic and diluted $(0.79) $(0.50)

SHARES USED IN COMPUTING NET

LOSS PER COMMON SHARE

Basic and diluted 43,718,077 43,506,236

Balance Sheet Information:

March 31, 2008 December 31, 2007*

(unaudited)

Cash, cash equivalents, interest

receivable and investment securities $39,560 $64,682

License receivable 8,000 --

Total assets 52,775 81,061

Accumulated deficit (312,810) (278,274)

Stockholders' equity 10,845 44,422

* Condensed from audited financial statements.


'/>"/>
SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
2. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
3. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
4. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
5. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
6. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
7. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
8. Keryx Biopharmaceuticals Announces Additions to Management Team
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
11. Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- Boston Scientific Corporation (NYSE: BSX ) ... $2 billion aggregate principal amount of its senior notes ... offering consists of $850 million of 4.50 percent notes ... due January 2020 and $300 million of 7.375 percent ... use the net proceeds for general corporate purposes, including ...
(Date:12/14/2009)... has completed the delivery of Brookfield Engineering’s Powder Flow Tester ... enclosure with a smaller footprint and more compact design. ... ... 2009 -- ThermoFab, a US-based thermoforming company, has completed the ... move from sheet metal to a plastic enclosure with a ...
(Date:12/11/2009)... 2009 miRagen Therapeutics, Inc., a biopharmaceutical company ... microRNA-based therapeutics for cardiovascular and muscle disease, today ... (miR-206) plays a crucial role in the progression ... disease) and in neuromuscular synaptic regeneration in mice. ... issue of the journal Science , reveal ...
(Date:12/11/2009)... December 11 Algeta ASA (OSE: ... first clinical center in the,US, the Tulane ... patients,in the phase III clinical study of ... hormone-refractory) prostate cancer,(CRPC) that has metastasized to ... The ALSYMPCA (ALpharadin in SYMptomatic Prostate CAncer) ...
Breaking Biology Technology:Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4
... discovering how the widely used natural insecticide Bt kills insects. ... the cells of an insect,s gut was the key to ... , Some insects have developed resistance to Bt toxins, ... such as cotton and corn and also disease-carrying mosquitoes. ...
... and mechanical properties of the carbon nanotube, a team ... single fiber of that material. , Fixed between two ... roles of a radio--antenna, tunable filter, amplifier and demodulator--to ... and play it back through an attached speaker. , ...
... 1 Pharmasset, Inc.,(Nasdaq: VRUS ) ... first Chief,Development Officer, responsible for coordinating the ... programs. Dr. Rogers joins,Pharmasset from GlaxoSmithKline, where ... of Viral Diseases, responsible for antiviral discovery,activities ...
Other Biology Technology:New designer toxins kill Bt-resistant insect pests 2New designer toxins kill Bt-resistant insect pests 3World's smallest radio fits in the palm of the hand...of an ant 2World's smallest radio fits in the palm of the hand...of an ant 3Pharmasset Appoints Michael Rogers as Chief Development Officer 2Pharmasset Appoints Michael Rogers as Chief Development Officer 3
(Date:12/11/2009)... demand for premium fruit increases, growers are being ... And to boost their bottom line, orchard owners ... fruit quality while reducing labor costs. , Hand ... produce larger, healthier fruit, is among the most ... on fruit production overhead, and, ultimately, prices paid ...
(Date:12/11/2009)... studying how bacteria under stress collectively weigh and initiate ... into how humans make strategic decisions that affect their ... , Their study, published this week in the early ... National Academy of Sciences , was accomplished when the ... describe the complex interplay of genes and proteins that ...
(Date:12/11/2009)... For nearly two decades, Ivy Pike, an associate professor ... studying ethnic groups in rural northern Kenya to understand ... a living there. , The results of her and ... warfare in three pastoralist communities of northern Kenya: A ... of Social Science and Medicine , in collaboration ...
Breaking Biology News(10 mins):Horizontal string trimmer reduces labor costs, increases peach size 2Bacteria provide new insights into human decision making 2Bacteria provide new insights into human decision making 3Bacteria provide new insights into human decision making 4Bacteria provide new insights into human decision making 5UA-led study grapples with health effects of low-intensity warfare 2Cost Conscious Texans Find Relief with Direct Access Lab Testing 52629 1Cost Conscious Texans Find Relief with Direct Access Lab Testing 52629 2Embarrassing illnesses no bar to information sharing 52625 1Embarrassing illnesses no bar to information sharing 52625 2URI researcher sheds light on man eating squid 3B finds them timid non threatening 9340 1URI researcher sheds light on man eating squid 3B finds them timid non threatening 9340 2URI researcher sheds light on man eating squid 3B finds them timid non threatening 9340 3
... the body’s own natural "waste disposal" chemistry to mop up ... patients with urea cycle disorders --- most of them children ... Journal of Medicine summarizing a quarter century of experience with ... sodium benzoate, two chemicals the body already makes to carry ...
... the United States, how long would it take for a ... stimulating an immune response? , A new national study ... to answer this question. , General routine vaccinations for ... the world was declared free of smallpox in 1980. But ...
... pistachios may lower cholesterol and provide the antioxidants usually ... according to a team of researchers. , "Pistachio amounts ... handfuls ?reduced risk for cardiovascular disease by significantly reducing ... lipoprotein ratios," says Sarah K. Gebauer, graduate student in ...
Other Biology News:An 'elegant' idea proves its worth 25 years later 2Smallpox outbreak: How long would it take for vaccines to protect people? Would it work? 2Pistachios lower cholesterol, provide antioxidants 2Pistachios lower cholesterol, provide antioxidants 3
Mouse monoclonal [J53] to Thyroid Hormone Receptor beta 1 ( Abpromise for all tested applications). entrezGeneID: 7068 SwissProtID: P10828...
TNF-Related Apoptosis Inducing Ligand-Receptor-1...
Request Info...
Recognizes NSCL1. The molecular weight of the protein is 14,616 Daltons....
Biology Products: